AUS

Helius Medical Technologies, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Retrieved on: 
Wednesday, August 11, 2021
Acceleration, Employment, Multiple sclerosis, Patient, Sale, European Union, Union, TSX, HSM, MS, Helios, GLOBE, Company, Nasdaq, HSDT, AUS, Ed Westwick, Pons, Traumatic brain injury, Tongue

The equity award was approved in accordance with Nasdaq Listing Rule 5635(c)(4), which also requires a public announcement of equity awards that are not made under a stockholder approved equity plan.

Key Points: 
  • The equity award was approved in accordance with Nasdaq Listing Rule 5635(c)(4), which also requires a public announcement of equity awards that are not made under a stockholder approved equity plan.
  • The option award has an exercise price of$15.39per share, the closing price of Helius common stock onAugust 10, 2021, the date of the grant.
  • Helius Medical Technologies is a neurotech company focused on neurological wellness.
  • Westwicke on behalf of Helius Medical Technologies, Inc.

Helius Medical Technologies, Inc. Launches New Website for U.S.-Based Patients and Physicians

Retrieved on: 
Wednesday, August 11, 2021
HSM, News, HSDT, Company, Patient, Traumatic brain injury, Union, MS, Physician, Contract, U.S. Securities and Exchange Commission, Toronto Stock Exchange, Internet, Technology, Program, Forward-looking statement, Therapy, European Union, Sale, Private Securities Litigation Reform Act, COVID-19, MCIT, Tongue, Ed Westwick, Medicare, Awareness, Nasdaq, Pons, TSX, FDA, GLOBE, Regulation, Multiple sclerosis, Growth, AUS, Pharmaceutical industry

NEWTOWN, Pa., Aug. 11, 2021 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (Helius or the Company), a neurotech company focused on neurological wellness, today announced that the Company has launched a new website: https://ponstreatment.com , created to serve as a resource for U.S.-based patients and physicians.

Key Points: 
  • NEWTOWN, Pa., Aug. 11, 2021 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (Helius or the Company), a neurotech company focused on neurological wellness, today announced that the Company has launched a new website: https://ponstreatment.com , created to serve as a resource for U.S.-based patients and physicians.
  • The website is designed to provide both audiences with information on the Companys PoNS Treatment and enable them to connect with Helius to learn more information, ask questions and receive future updates.
  • We are pleased to expand our online resources for U.S.-based patients and physicians as we prepare to commercialize our PoNS technology during the first quarter of 2022, said Dane Andreeff, President and Chief Executive Officer of Helius.
  • Helius Medical Technologies is a neurotech company focused on neurological wellness.

Floify Launches New Mortgage Origination Platform for Wholesale Lenders

Retrieved on: 
Tuesday, August 10, 2021
Communication, Collection, AUS, Sale, TPO, Documentation, Solution, Efficiency, CRM, Real estate, Bank

BOULDER, Colo., Aug. 10, 2021 /PRNewswire-PRWeb/ -- Floify , the leading provider of digital mortgage lending technology, announced today it has released Floify TPO, the company's new automated loan submission platform that directly supports wholesale lenders and their third-party originators.

Key Points: 
  • BOULDER, Colo., Aug. 10, 2021 /PRNewswire-PRWeb/ -- Floify , the leading provider of digital mortgage lending technology, announced today it has released Floify TPO, the company's new automated loan submission platform that directly supports wholesale lenders and their third-party originators.
  • Wholesale lenders utilize Floify TPO to dramatically improve visibility, communication, and efficiency throughout their TPO channel, resulting in shorter loan cycle times and a dynamic mortgage borrowing experience.
  • "Floify TPO provides a winning scenario for wholesale lenders, third-party originators and the borrowers they serve," said Floify CEO Dave Sims.
  • When using the Floify point-of-sale system to automate the mortgage process, loan originators have reported closing loans up to 10 days faster.

Arc Home LLC Implements Indecomm's BotGenius™ to Automate Middle Office Mortgage Operations

Retrieved on: 
Monday, August 9, 2021
Technology, Software, Longevity, Compliance, CEO, Collateral, NY, LES, Time, Industry, Fraud, Review, RPA, Solution, AUS, Compact disc, Automation, QM, Communication, Education, Collection, Bank, Real estate

BotGenius is a collection of software robots pre-built to emulate human computer interaction for specific, standardized middle office tasks, processes, and workflows in the mortgage industry.

Key Points: 
  • BotGenius is a collection of software robots pre-built to emulate human computer interaction for specific, standardized middle office tasks, processes, and workflows in the mortgage industry.
  • The bulk of time and expense in the mortgage loan origination process is in processing and underwriting, or the "middle office."
  • While the "middle office" is the hardest part of the mortgage loan lifecycle to automate, it is the loan stage that provides mortgage lenders with the biggest opportunity for gaining efficiencies.
  • To learn more about Indecomm's BotGenius solutions and how you can automate your middle office mortgage workflows, visit the corporate website at https://botgenius.net .